Sreepriya Prasannan

An explanation of the 5 modules of the ICH Common Technical Document (CTD) format required for global drug marketing authorization applications.

As global health systems enforce tighter pricing controls under the US IRA and EU health technology updates, biopharma majors are restructuring their R&D portfolios to manage clinical risks.

An educational review of data integrity requirements in pharma QC, covering ALCOA+ principles, audit trails, and data security.

A structured tutorial on handling quality control laboratory OOS results, conducting Phase I/II investigations, and implementing corrective actions.

Global research pipelines and venture capital inflows are concentrating in targeted cancer therapy with ADCs and next-generation cardiometabolic GLP-1 oral weight-loss compounds.

A guide to validating computerized lab and production systems using the GAMP 5 V-model lifecycle, risk assessments, and electronic records compliance.

Legal firm Fieldfisher will host a scaling roundtable for B2B founders and sales leaders in Dublin on July 1st, featuring legal guidance from Jamie Woodcock and leadership coaching from Fergus McFadden.

Presented at the ACI’s Annual General Meeting in Carlow by Minister Jennifer Murnane O’Connor and ACI Board member John Devlin, the new three-year strategy focuses on workforce recognition, professional development, and regulatory transitions.

The UK government and industry partners have unveiled a £85 million funding package for 12 pioneering projects aimed at transforming obesity care, integrating digital tools, and optimizing GLP-1 clinical pathways.

A detailed, practical guide to Ireland's Non-EEA Family Reunification Policy as updated in 2026. Covers the new financial thresholds for all sponsor categories, country-specific waiting periods, step-by-step application process, and a comprehensive pre-application checklist - essential reading for pharmacists, healthcare workers, and life science professionals bringing family to Ireland.

As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.

A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.